News & Trends

• 24 2022-11

  IND acceptance by NMPA for SAL0119 tablets for the...
• 10 2022-11

  The marketing application of SAL0107 for the treat...
• 10 2022-11

  Speeding up the innovation, Salubris moves into th...
• 24 2022-10

  Using AI-enabled drug discovery tools, Salubris ha...
• 17 2022-10

  Clinical progress of SAL0108 for the treatment of ...